Its lead program, NIV-001, is a proprietary combination of three repurposed FDA-approved drugs designed to enhance neuroplasticity and improve motor recovery in stroke survivorsan estimated $20B unmet need in the U.S
*Produced in an FDA-approved, CGMP-certified facility
[Link] Synthesis of [3H]acetylcholine from [3H]acetyl-L-carnitine was demonstrated in vitro by coupling the enzyme systems choline acetyltransferase and carnitine acetyltransferase. Chen, N, et al, L-carnitine for cognitive enhancement in people without cognitive impairment. in Cochrane Database of Systematic Reviews , Volume 26, Issue 3, March 2017
doi: 10.1371/journal.pone.0100777 155 KeQShiCLvYWangLLuoJJiangLet al
doi: 10.3892/IJMM.2025.5515 Summary Keywords glucagon-like peptide-1, type 2 diabetes, endothelial function, obesity, metabolic syndrome Citation Hammad BF, Zafar N, Ullah M, Faisal SJ, Iftikhar F, Waheed H, Muzaffar MW, Ahmed K, Ashraf F, Zahid K, Akhtar M and Mahmmoud Fadelallah Eljack M (2025) Exploring the multifaceted roles of GLP-1 receptor agonists
N-Acetyl Cysteine (NAC): Boosts natural glutathione production